Tenders of Aok Rheinland Pfalz Saarland Die Gesundheitskasse
Tenders of Aok Rheinland Pfalz Saarland Die Gesundheitskasse
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Laboratory Equipment and Services
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Etanercept (l04ab01) Im Rahmen Eines Sogenannten Open-house-modells.
Closing Date31 May 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Civil And Construction
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Bempedoinsäure (c10ax15) Im Rahmen Eines Sogenannten Open-house-modells.
Closing Date31 May 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Electronics Equipment...+2Electrical Goods and Equipments, Electrical and Electronics
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Ustekinumab (l04ac05) Im Rahmen Eines Sogenannten Open-house-modells.
Closing Date31 May 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient cariprazine (N05AX15) within the framework of a so-called open-house model.
Closing Date30 Apr 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient follitropin alfa (G03GA05) within the framework of a so-called open-house model.
Closing Date30 Apr 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient tacrolimus (L04AD02) within the framework of a so-called open-house model.
Closing Date30 Apr 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient ganirelix (H01CC01) within the framework of a so-called open-house model.
Closing Date30 Apr 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient calcipotriol and betamethasone (D05AX22), excluding ointments within the framework of a so-called open-house model.
Closing Date30 Apr 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient lipegfilgrastim (L03AA14) within the framework of a so-called open-house model.
Closing Date30 Apr 2026
Tender AmountRefer Documents
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Civil And Construction
Germany
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Mebeverin (a03aa04) Rahmen Eines Sogenannten Open-house-modells.
Closing Date30 Apr 2026
Tender AmountRefer Documents
81-90 of 254 active Tenders